ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 03 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide
Prostate Cancer Awareness Month 2020: Immunotherapy, state-of-the-art radiotherapy, olaparib and PSA screening 24 Mar 2020 March is Prostate Cancer Awareness Month. Web Editor Dave Morgan reviews four recent news stories covering different types of prostate cancer research taking place at The Institute of Cancer Research. Find out more Show/Hide
Men’s Health Awareness Month: 12 months of progress into male cancer research at the ICR 21 Nov 2019 November is Men’s Health Awareness Month, an important time to raise awareness of male cancers. Our Web Editor, Dave Morgan, looks into six advances made by our researchers into prostate, testicular and urological cancers in the last year. Find out more Show/Hide
“Here you really can make a difference” – Professor Chris Lord reflects on the biggest developments in his career so far 18 Oct 2018